Forschungszentrum Ruhr KliFoCenter GmbH

Witten, North Rhine-Westphalia 58455

0 studies enrolling now · 2 studies all time

What they study most

Acute Myocardial Infarction, Atrial Fibrillation, Prevention of Stroke or Systemic Embolism

Studies at this site

• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early
• Study to Gather Information About the Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following an Acute Heart Attack — Completed